Options are financial instruments that give the holders the right to buy or sell underlying stocks or matter at a future point in time at an agreed price. The Black Scholes Models is a tool for pricing equity options. Before this, there was no way to price standard options in a very real sense. This model was developed in 1973 which is another way a mathematical model describing the behaviour of market prices of financial instruments in time (Hull, John C. 2000, pp. 231).
The Black-Scholes formula assumes that the returns of the underlying asset are Gaussian, or equivalently that the asset value follows a diffusion (In common parlance, the term refers to scattering a notion of distribution of making available (distribution of a product, information), even "spray" (diffuser) geometric Brownian. The first four are obvious data, only the volatility asset is difficult to assess. Two analysts will have an opinion different (In mathematics, is defined differently in algebraic number theory to measure the possible lack of duality) on the value of to choose.
One can also apply the formula to the inverse (In mathematics, the inverse of an element x of a set with an internal composition law written multiplicatively, is an element y such that x · y = y · x = 1, 1 denotes if). Given the price of the option is listed in the markets, which value of must be chosen so that the BS formula gives exactly that price. This gives the "implied volatility" that has a great practical and theoretical (Hull, John C., 2000, pp. 23).
GoodPharma Patent valuation through Black Scholes-Merton Model
Patent Granted
20 years
Development cost
1.5 Billion Pounds
Present Value
1 Billion Pounds
Expected Variance
0.03 17.32%
Riskless bond 20 years
10%
Assumptions
All the assumption of Black Scholes-Merton Model apply
The project present value & value of variance known
Input in the formula
Present value of the cash inflows taking for project
Function of technical and environmental change has been taken as Present Value of Variance
Current Value of developing project cost commercial utilization
Risk-less Rate of interest which match up with product patent length
Length of the product patent to project
After the development, the expected cash-flow from the project
PROJECT INPUT
Present Value of cash flow of the project
1000000000
Project Standard Deviation
17.32%
OPTION DERIVATIVE INPUT
Cost of Developing project
1500000000
Tenure of the patent project
20
GENERAL INPUTS
Riskless 20 years bond rate
10.00%
VALUATION FOR LONG-TERM OPTION
Price of Stock
1000000000
Price of Strike
1500000000
Expiration (in years)
20
Bond interest rate
10.00%
Variance
0.030
Annual dividend yield
5.00%
d1 =
1.15484
N(d1) =
0.87592
d2 =
0.38024
N(d2) =
0.64812
Value of the product patent/project right =
190,663,942
Comments on the Results
It is common that an inventor wishes, for various reasons; estimate the value of the patent it holds. Indeed, patents are an intangible capital of the company. They may be subject to license, implying that the price of the object; in this case the patent is determined (Munari F., 2011, pp. 160). Patents are an asset to company, just as a building. In addition, they allow the company to innovate in the competitive ...